The increased incidence of fungal infections
during the last decade has been well-documented.
Given that one of the most important factors contributing
to this phenomenon is the increased numbers of immunocompromised
individuals, it is perhaps not surprising that
species previously not associated with human disease and
novel species previously unknown to science have been
identified as potential pathogens (e.g., Penicillium marneffei
, Emmonsia pasteuriana and Candida dubliniensis)